Research Article

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes

Figure 2

eNOS expression, activity, and urinary excretion of nitric oxide metabolites in nondiabetic (control) and diabetic Ren-2 rats at 24 days. (a) eNOS mRNA determined by real-time PCR. (b) Immunoblotting kidney homogenates from control and diabetic Ren-2 rats for total eNOS protein and eNOS Ser1177 phosphorylation (p-eNOS), indicative of enzyme activation. (c) Urinary nitrate/nitrite. ((d) and (e)) Immunohistochemistry for eNOS in kidney sections from control (d) and diabetic (e) Ren-2 rats. Original magnification ×160. AU: arbitrary units. ,   , and   .
201475.fig.002a
(a)
201475.fig.002b
(b)
201475.fig.002c
(c)
201475.fig.002d
(d)
201475.fig.002e
(e)